HIV Infections: all 4,342 studies
Page 20 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of TenofovirCompletedNCT02588287Not applicable
- The I-Score Study: Developing a New Patient-Reported Tool for the Routine HIV Care of Patients on Antiretroviral TherapyStatus unknownNCT02586584
- Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg.CompletedNCT02583464Phase 1
- Interventions to Improve HIV Care Engagement After Hospital DischargeCompletedNCT02578654Not applicable
- Study on Effects of BMS-955176 on the Pharmacokinetics of Probe SubstratesCompletedNCT02578277Phase 1
- A Study to Determine the Effect of Multiple Doses of BMS-955176 on the Electrocardiograph of Healthy SubjectsTerminatedNCT02576119Phase 1
- Antiviral Pharmacology and Adherence in Drug UsersCompletedNCT02573376Not applicable
- A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed PatientsCompletedNCT02572947Phase 2
- A Sleep Program to Improve Sleep Quality in People With HIVTerminatedNCT02571595Not applicable
- Cognitive Training for the Remediation of Functional Brain Health in HIVCompletedNCT02571504Not applicable
- Targeting Effective Analgesia in Clinics for HIV - InterventionCompletedNCT02564341Not applicable
- Being Responsible for Ourselves HIV Risk Reduction for Black MSMCompletedNCT02561286Not applicable
- Fostering Resilience to Psychosocial and HIV Risk in Indian MSMCompletedNCT02556294Not applicable
- A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)WithdrawnNCT02556086Phase 2
- Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV InfectionCompletedNCT02553369
- A Study to Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on PharmacokineticsCompletedNCT02547870Phase 1
- Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and SteatosisStatus unknownNCT02542020
- Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese SubjectsCompletedNCT02539576Phase 1
- Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected PersonsCompletedNCT02538952Phase 4
- Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.CompletedNCT02537236Phase 3
- Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV InfectionCompletedNCT02532348
- Energy Expenditure of People Living With HIV/AIDSCompletedNCT02530827
- Text Messaging to Improve HIV Testing Among Young Women in KenyaCompletedNCT02527135Not applicable
- A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)CompletedNCT02527096Phase 2
- Targeting Effective Analgesia in Clinics for HIV - Patient CohortCompletedNCT02525731
- Birmingham Access to Care StudyCompletedNCT02525146Not applicable
- A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Individuals in ChinaCompletedNCT02516930Not applicable
- Friends for Life Circles for Option B PlusCompletedNCT02515370Not applicable
- Outcomes of HIV Infected Individuals After Ten Years on Antiretroviral TreatmentStatus unknownNCT02514707
- SMS as an Incentive To Adhere (SITA) - An Intervention Communicating Social Norms by SMS to Improve ARV AdherenceCompletedNCT02514356Not applicable
- Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 ReservoirCompletedNCT02513901Phase 1/2
- Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in AndalusiaStatus unknownNCT02511496
- Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release TabletCompletedNCT02508064Phase 1
- Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsActive, not recruitingNCT02500849Phase 1
- Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated ToxicityWithdrawnNCT02499978Phase 2/3
- Evaluating Demand Creation Strategies for Voluntary Medical Male Circumcision (VMMC) in KenyaCompletedNCT02497989Not applicable
- Community-Based Peer Facilitator Intervention (Zimbabwe)CompletedNCT02496793Not applicable
- Demand Creation for Couples' HIV Counseling and TestingStatus unknownNCT02492061Not applicable
- Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological SuppressionCompletedNCT02491242
- Mother and Infant Visit Adherence and Treatment Engagement StudyCompletedNCT02491177Not applicable
- Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500CompletedNCT02489487Phase 1
- Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy VolunteersCompletedNCT02489435Phase 1
- Dual Therapy With Boosted Darunavir + DolutegravirCompletedNCT02486133Phase 3
- Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 InfectionCompletedNCT02485509Phase 1/2
- CPAP Improving Mortality for Pneumonia in African Children TrialTerminatedNCT02484183Not applicable
- First Event of Infection by HIV-1 of Uterine Vaginal TissueStatus unknownNCT02481622
- Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip TechniqueCompletedNCT02481492Not applicable
- A Open-label, Drug-Drug Interaction With Maraviroc (DDI)CompletedNCT02480894Phase 1
- A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)CompletedNCT02480881Phase 1
- Demonstration Project of PrEP Among Female Sex Workers in Dakar, SenegalCompletedNCT02474303Not applicable
- Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNSCompletedNCT02470351
- Single-dose Pharmacokinetics of BMS-626529, Administered as BMS-663068, in Subjects With Hepatic Impairment Compared to Healthy SubjectsCompletedNCT02467335Phase 1
- Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader ModelCompletedNCT02464423Not applicable
- Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South AfricaWithdrawnNCT02462772Phase 2
- Clinical Evaluation of the Xpert® HIV-1 VLCompletedNCT02461576
- ART Readiness in HIV-infected Pregnant WomenCompletedNCT02459678Not applicable
- Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive SubjectsCompletedNCT02456558Phase 1
- Regular HIV Testing Among At-Risk Latino MenCompletedNCT02454725Not applicable
- Safety, PK and PD Study of ABX464 in Untreated HIV PatientsCompletedNCT02452242Phase 2
- Intervention Development for Social Stress, Mental Health, and HIV Risk MSMCompletedNCT02448186Not applicable
- Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, NigeriaCompletedNCT02447159Not applicable
- Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV InfectionCompletedNCT02437851Phase 2
- Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHACompletedNCT02433743Not applicable
- Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected AdultsCompletedNCT02431767Phase 1
- Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related QualityCompletedNCT02427204
- Risk of CV Events With EFV vs. EFV-free RegimensCompletedNCT02426866
- Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and AdolescentsCompletedNCT02426840Phase 3
- Hybrid STTR Intervention for Heterosexuals: Anonymous Testing and Confidential Care LinkageCompletedNCT02421159Not applicable
- Pharmacokinetics of Two Intravaginal Rings (IVRs) Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048CompletedNCT02419456Phase 1
- Health-Related Symptom Questionnaires in Measuring Quality of Life in HIV-Infected Participants Treated or Monitored for Anal LesionsCompletedNCT02418494
- Factors Affecting PrEP AdherenceCompletedNCT02411630
- Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy SubjectsCompletedNCT02411435Phase 1
- Evaluating a Microfinance Intervention for Vulnerable Women in KazakhstanCompletedNCT02406482Not applicable
- Jamii Bora: A Home-Based Couples InterventionCompletedNCT02403583Not applicable
- The Dolutegravir Antiretroviral Mono-Therapy for HIV TrialCompletedNCT02401828Phase 4
- Pericardial Fat and Inflammation in HIV Patients and ControlsCompletedNCT02399384
- Intervention of HIV, Drug Use and the Criminal Justice System in MalaysiaCompletedNCT02396979Phase 4
- Accuracy Evaluation of the BD FACS Presto SystemCompletedNCT02396355
- Cognitive-Based Compassion Training (CBCT) for People Living With HIV (PLHIV)CompletedNCT02395289Not applicable
- HIV Medication Adherence in Underserved PopulationsStatus unknownNCT02392884Not applicable
- Simplifying the Shang Ring Technique for Circumcision of Men and BoysCompletedNCT02390310Not applicable
- A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected PatientsCompletedNCT02388594Phase 1
- Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 PatientsCompletedNCT02384967Phase 2
- Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in ChildrenCompletedNCT02383108Phase 2/3
- Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDSCompletedNCT02376582Phase 1
- Relative Oral Bioavailability Study of Different Fixed Dose Combinations of Dolutegravir and Rilpivirine in Healthy SubjectsCompletedNCT02373930Phase 1
- Test Albuvirtide in Experienced PatientsCompletedNCT02369965Phase 3
- REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy StudyStatus unknownNCT02366026Phase 3
- HIV & Drug Abuse Prevention for South African MenCompletedNCT02358226Phase 3
- Safety and Pharmacokinetics of Intravaginal Rings Containing Vicriviroc (MK-4176) and/or MK-2048CompletedNCT02356302Phase 1
- A Study to Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy VolunteersCompletedNCT02354950Phase 1
- Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal ImpairmentCompletedNCT02354937Phase 1
- Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable PopulationsCompletedNCT02354053Phase 4
- Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative AdultsCompletedNCT02346084Phase 1
- Relative Bioavailability Study of Phase III Tablet Formulation of CabotegravirCompletedNCT02345707Phase 1
- HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionWithdrawnNCT02343666Phase 1
- Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in GermanyCompletedNCT02342769
- Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ WomenTerminatedNCT02338141Not applicable
- Eliciting Affect in Teens in a Virtual World (Project AVATAR)CompletedNCT02338063Phase 1/2
- Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaActive, not recruitingNCT02337985Phase 1